JNK anticorps (AA 228-451)
Aperçu rapide pour JNK anticorps (AA 228-451) (ABIN363363)
Antigène
Voir toutes JNK (MAPK8) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 228-451
-
Specificité
- Reacts with ~53 kDa (alpha form) and at ~42 kDa (beta form) JNK1 from C
-
Réactivité croisée (Details)
- elegans protein. Does not appear to detect mammalian JNK protein.
-
Purification
- Antiserum
-
Immunogène
- A recombinant C. elegans JNK1 alpha protein (residues 228-451)
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- IP : 1/2 000 - WB : 1/2 000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- , Sodium azide 0.05 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C/-80 °C
-
Stockage commentaire
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
-
- JNK (MAPK8) (Mitogen-Activated Protein Kinase 8 (MAPK8))
-
Autre désignation
- JNK1
-
Pathways
- Signalisation MAPK, Signalisation WNT, Signalisation TLR, Fc-epsilon Receptor Signaling Pathway, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Hepatitis C, Toll-Like Receptors Cascades, Signaling of Hepatocyte Growth Factor Receptor, S100 Proteins
Antigène
-